Trial Profile
A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2014
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- Sponsors Astellas Pharma
- 22 Apr 2014 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
- 15 Dec 2011 New trial record